88 related articles for article (PubMed ID: 8718547)
1. [Expression of glutathione S-transferase pi and numerical aberration of chromosome 11 in human ovarian cancer as a prognostic indicator].
Yokoyama Y; Fukushi Y; Kunugi T; Maruyama H; Sato S; Saito Y
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):118-24. PubMed ID: 8718547
[TBL] [Abstract][Full Text] [Related]
2. [The expression of glutathione S-transferase pi in human ovarian cancer as an indicator of resistance to chemotherapy].
Li L; Yao D; Chen X
Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):95-7. PubMed ID: 10682429
[TBL] [Abstract][Full Text] [Related]
3. [Expression of glutathione S-transferase-pi in operative specimens as marker of chemoresistance in patients with ovarian cancer].
Huang J; Gu M; Chen C
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):458-61. PubMed ID: 9639737
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
Cheng X; Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Okada M; Terakawa N
Cancer; 1997 Feb; 79(3):521-7. PubMed ID: 9028363
[TBL] [Abstract][Full Text] [Related]
5. Estimation of glutathione S-transferase and its Pi isoenzyme in tumor tissues and sera of patients with ovarian cancer.
Ghalia AA; Rabboh NA; el Shalakani A; Seada L; Khalifa A
Anticancer Res; 2000; 20(2B):1229-35. PubMed ID: 10810426
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
Bai F; Nakanishi Y; Kawasaki M; Takayama K; Yatsunami J; Pei XH; Tsuruta N; Wakamatsu K; Hara N
Cancer; 1996 Aug; 78(3):416-21. PubMed ID: 8697385
[TBL] [Abstract][Full Text] [Related]
8. Long-term prognostic factors for chemotherapy of ovarian cancer.
Muso H
Osaka City Med J; 1998 Dec; 44(2):155-71. PubMed ID: 10097596
[TBL] [Abstract][Full Text] [Related]
9. Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy.
Hamada S; Kamada M; Furumoto H; Hirao T; Aono T
Gynecol Oncol; 1994 Mar; 52(3):313-9. PubMed ID: 8157188
[TBL] [Abstract][Full Text] [Related]
10. [Value of P-glycoprotein and glutathione S-transferase-pi as chemo-resistant indicators in ovarian cancers].
Zhang F; Qi L; Chen H
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):313-6. PubMed ID: 11783115
[TBL] [Abstract][Full Text] [Related]
11. Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistance in ovarian cancer.
Tanner B; Hengstler JG; Dietrich B; Henrich M; Steinberg P; Weikel W; Meinert R; Kaina B; Oesch F; Knapstein PG
Gynecol Oncol; 1997 Apr; 65(1):54-62. PubMed ID: 9103391
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.
Miyatake K; Gemba K; Ueoka H; Nishii K; Kiura K; Tabata M; Shibayama T; Takigawa N; Kawaraya M; Tanimoto M
Anticancer Res; 2003; 23(3C):2829-36. PubMed ID: 12926120
[TBL] [Abstract][Full Text] [Related]
13. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.
Silvestrini R; Daidone MG; Veneroni S; Benini E; Scarfone G; Zanaboni F; Villa A; Presti M; Danese S; Bolis G
Cancer; 1998 Jan; 82(1):159-67. PubMed ID: 9428493
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival.
Beeghly A; Katsaros D; Chen H; Fracchioli S; Zhang Y; Massobrio M; Risch H; Jones B; Yu H
Gynecol Oncol; 2006 Feb; 100(2):330-7. PubMed ID: 16199080
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.
Ali-Osman F; Brunner JM; Kutluk TM; Hess K
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2253-61. PubMed ID: 9815622
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
[TBL] [Abstract][Full Text] [Related]
17. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy.
Unsal M; Akpolat I; Kandemir B
Saudi Med J; 2003 May; 24(5):493-8. PubMed ID: 12847624
[TBL] [Abstract][Full Text] [Related]
18. Nuclear morphometry and glutathione S-transferase pi expression in breast cancer.
Huang J; Bay BH; Tan PH
Oncol Rep; 2000; 7(3):609-13. PubMed ID: 10767377
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
Arai T; Yasuda Y; Takaya T; Hayakawa K; Toshima S; Shibuya C; Kashiki Y; Yoshimi N; Shibayama M
Cancer Detect Prev; 2000; 24(3):252-7. PubMed ID: 10975287
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ
Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]